相关实验视频

Updated: Jul 26, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

利图西马布在CANOMAD中的有效性:系统性审查

Alex S Aguirre¹, Ricardo A Vivanco², Juan Fernando Ortiz³

¹School of Medicine, Universidad San Francisco de Quito, Quito, ECU.

|June 20, 2023

概括

在慢性心力衰竭神经病,眼,IgM偏蛋白,冷凝蛋白和disialosyl抗体 (CANOMAD) 中早期治疗rituximab可以改善结果. 在这个系统性审查中,早期接受Rituximab的患者表现出更好的临床反应和持续的效果.

科学领域:

神经学神经学
免疫学免疫学免疫学
罕见疾病罕见疾病

背景情况:

慢性性神经病变,眼膜,免疫球蛋白M (IgM) 副蛋白,感冒聚合素和disialosyl抗体 (CANOMAD) 是一种罕见的疾病,治疗方法不清楚.
对CANOMAD的理解和诊断已经取得了进展,但治疗上的共识仍然难以捉摸.

研究的目的:

系统地审查瑞图西马布在治疗CANOMAD中的疗效.
为了研究用Rituximab治疗的CANOMAD患者的临床和生物反应.

主要方法:

按照PRISMA和MOOSE指南进行系统审查.
包括病例报告,病例系列和观察性研究,涉及用Rituximab治疗的CANOMAD患者.
使用JBI批判性评估检查清单和ROBINS-I工具进行偏差评估.

主要成果:

分析了34名患者;临床反应包括3例完全恢复 (CR),5例部分反应 (PR),15例稳定疾病 (SD),11例进展.
生物反应显示CR在6,PR在12,SD在8和进展在1的27名患者降低了抗体标位.
早期治疗和更长的随访与更好的临床结果 (CR) 相相关.

结论:

在CANOMAD中早期使用Rituximab与改善的临床结果和持续的效果有关.
神经病变的轴突和混合模式可能表明CANOMAD的预后较差.
利图西马布似乎是对CANOMAD的一种有前途的治疗选择,需要进一步研究.

关键词:

凸骨的症状凸骨的症状这里可以看到Canonomad.马病是一种性质的马病.在 igm igm 里面.眼睛的眼睛损伤 (Ophthalmoplegia) 是一种这就是Rituximab.

更多相关视频

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

相关概念视频

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...